Imidazole → HCID 89397429, compound
Reaction equation
[OH:1][C@H:2]1[CH2:6][CH2:5][N:4]([N:7]=[O:8])[C@@H:3]1[C:9]([O:11][CH3:12])=[O:10].N1C=CN=C1.[CH3:18][C:19]([Si:22](Cl)([CH3:24])[CH3:23])([CH3:21])[CH3:20]>C(Cl)Cl>[Si:22]([O:1][C@H:2]1[CH2:6][CH2:5][N:4]([N:7]=[O:8])[C@@H:3]1[C:9]([O:11][CH3:12])=[O:10])([C:19]([CH3:21])([CH3:20])[CH3:18])([CH3:24])[CH3:23]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (2S,3S)-methyl 3-hydroxy-1-nitrosopyrrolidine-2-carboxylate (13 g, 0.0742 moles) in DCM (150 mL) at room temperature were added imidazole (15.2 g, 0.224 moles) and TBDMS-Cl (22.5 g, 0.149 moles) and the mixture was stirred at room temperature for 3 h. The reaction mixture was diluted with DCM and washed with water, brine, dried over Na2SO4 and concentrated. Purification by column chromatography over silica gel using 10% EtOAc in hexane as a solvent provided the title compound.
Workup
- washwashed with water, brine
- dry with materialdried over Na2SO4
- concentrationconcentrated
- customPurification by column chromatography over silica gel using 10% EtOAc in hexane as a solvent
Sources & evidence
- ORD record
- ord-8fbd2e944adc4aac84356afac2745696
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09051326B2
Reaction notes
Loading…